Paper mill studies get cited by clinical guidelines, policy docs and more, analysis finds

The work, posted on arXiv on August 31, examined the fate of nearly 2,000 academic papers with one common factor: At least one coauthor lists the Pharmakon Neuroscience Network (PNN) as an institutional affiliation. But there’s one problem: the PNN is not a real network of scientists. Instead, it’s an authorship-for-sale scheme, as Retraction Watch reported in 2022.